TrialProstate cancer and prostatic diseases2021

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis.

Zhigang Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.